Old Web
English
Sign In
Acemap
>
authorDetail
>
Haixia Yang
Haixia Yang
West Virginia University
Pathology
Drug resistance
Lung cancer
Medicine
ALK-Positive
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PRC-2 epigenetic chromatin reprogramming in ALK-positive (ALK+) lung cancer initial emergence of precision drug resistance.
2018
Journal of Clinical Oncology
Patrick C. Ma
Xiaoliang Wu
Satoshi Komo
Zuan-Fu Lim
Haixia Yang
Kacey Rhodes
Brandon C. Jones
Daniel J. Lindner
Francisco A. Almeida
Veronique Neumeister
Vamsidhar Velcheti
Elena N. Pugacheva
Ivan Martinez
Lihong Yin
Sijin Wen
Zhenfeng Zhang
Show All
Source
Cite
Save
Citations (0)
Mass spectrometry biomolecular omics profiling and imaging to dissect the initial emergence of molecular drug resistance in ALK-positive (ALK+) lung cancer.
2018
Journal of Clinical Oncology
Xiaoliang Wu
Zuan-Fu Lim
Satoshi Komo
Callee M. Walsh
Haixia Yang
Lin Zhu
Kacey Rhodes
Brandon C. Jones
Elena N. Pugacheva
Matthew B. Smolkin
Erin H. Seeley
Patrick C. Ma
Show All
Source
Cite
Save
Citations (0)
MA07.09 Mass Spectrometry Profiling and Imaging Platform for Novel Precision Drug Resistance Biomarkers Discovery in EML4-ALK Lung Adenocarcinoma
2017
Journal of Thoracic Oncology
Patrick C. Ma
Pamela S. Cantrell
Callee M. Walsh
Sijin Wen
Satoshi Komo
Xiaoliang Wu
Haixia Yang
Erin H. Seeley
Show All
Source
Cite
Save
Citations (0)
AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
2017
Journal of Cancer Research and Clinical Oncology
Xiaoliang Wu
Wenjuan Ma
Qianghua Zhou
Haijuan Yan
Zuan-Fu Lim
Mayan Huang
Chuangzhong Deng
Xingsu Yu
Huifang Su
Satoshi Komo
Haixia Yang
Xinke Zhang
Sijin Wen
Zhenfeng Zhang
Patrick C. Ma
Show All
Source
Cite
Save
Citations (24)
1